Skip to main content
Livermore
Livermore
ZHEN

Personal Cfo Solutions, LLC

SEC CIK
0001677501
Latest filing
Aug 7, 2026

ACAD holding history

Acadia Pharmaceuticals Inc in every 13F filed by Personal Cfo Solutions, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACAD overviewAll 13F holders of ACADFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of ACAD by Personal Cfo Solutions, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−11,306−100.0%Sold outHolders
Q4 202511,306$302.0K<0.1%−8−0.1%ReducedHolders
Q3 202511,314$241.4K<0.1%+165+1.5%AddedHolders
Q2 202511,149$240.5K<0.1%−1,003−8.3%ReducedHolders
Q1 202512,152$201.8K<0.1%−78−0.6%ReducedHolders
Q4 202412,230$224.4K<0.1%+12,230NewHolders
Q3 20240$00.0%−12,614−100.0%Sold outHolders
Q2 202412,614$205.0K<0.1%−177−1.4%ReducedHolders
Q1 202412,791$236.5K<0.1%−37−0.3%ReducedHolders
Q4 202312,828$401.6K0.1%+20+0.2%AddedHolders
Q3 202312,808$266.9K0.1%+27+0.2%AddedHolders
Q2 202312,781$306.1K0.1%−79−0.6%ReducedHolders
Q1 202312,860$242.0K<0.1%+14+0.1%AddedHolders
Q4 202212,846$204.5K<0.1%−3,500−21.4%ReducedHolders
Q3 202216,346$267.0K0.1%00.0%UnchangedHolders
Q2 202216,346$230.0K0.1%+500+3.2%AddedHolders
Q1 202215,846$384.0K0.1%+1,000+6.7%AddedHolders
Q4 202114,846$347.0K0.1%−13,154−47.0%ReducedHolders
Q3 202128,000$465.0K0.1%+2,800+11.1%AddedHolders
Q2 202125,200$615.0K0.1%00.0%UnchangedHolders
Q1 202125,200$650.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.